← Eichor
Study identifier: NCT07565428 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Condition: Negative Symptoms of Schizophrenia  ·  Sponsor: Minerva Neurosciences

PhasePhase 3
Planned participants380
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

Evaluate the efficacy, as well as safety and pharmacokinetics, of Roluperidone in improving the negative symptoms of schizophrenia in adult subjects in Phase A of study, followed by Phase B of study to evaluate the relapse rate of Roluperidone and antipsychotic medications.

This description comes directly from the study's public registry record.

Talk to the study team

Chief Operating Officer  ·  617-600-7373  ·  info@minervaneurosciences.com

Always discuss trial participation with your own doctor first.

Locations (13)

Clinical Innovations, Inc. dba CITrialsBellflower, California, United StatesRecruiting
ProScience Research GroupCulver City, California, United StatesRecruiting
Collaborative Neuroscience Research, LLCGarden Grove, California, United StatesRecruiting
Clinical Innovations, Inc. dba CITrialsRiverside, California, United StatesRecruiting
Velocity Clinical Research, Hallandale BeachHallandale, Florida, United StatesRecruiting
Behavioral Clinical Research, Inc.Hollywood, Florida, United StatesRecruiting
ForCare Clinical ResearchTampa, Florida, United StatesRecruiting
Atlanta Center for Medical Research, LLCAtlanta, Georgia, United StatesRecruiting
CenExel iResearch, LLCDecatur, Georgia, United StatesRecruiting
CBH Health, LLC dba CenExelGaithersburg, Maryland, United StatesRecruiting
Hassman Research Institute, LLC dba CenExelMarlton, New Jersey, United StatesRecruiting
New York State Psychiatric InstituteNew York, New York, United StatesRecruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07565428